Product Information
CLOBAZAM 2.5 MG/ML SUSPENSION is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1608 per ML under NDC 59651040112. Its NADAC has been published 160 times since Jun 7, 2023.
Strength
2.5 mg/mL
Manufacturer
Aurobindo Pharma LimitedNDC
59651040112
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLOBAZAMApproval Type
Generic (ANDA)
FDA Application
ANDA214404On Market Since
3/24/2022
Pharmacological Classes
Price Statistics
The NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has been published 160 times since Jun 7, 2023, and over the history we have for it it has declined 46.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1608 per ML |
|---|---|
| All-time high | $0.3316 (Aug 16, 2023) |
| All-time low | $0.1530 (May 20, 2026) |
| 52-week high | $0.1928 |
| 52-week low | $0.1530 |
| Median price | $0.1940 |
| Average price | $0.2114 |
| Largest weekly change | +32.4% (Aug 21, 2024) |
| Weeks tracked | 160 |
| Tracking since | Jun 7, 2023 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLOBAZAM 2.5 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for CLOBAZAM 2.5 MG/ML SUSPENSION, manufactured by Aurobindo Pharma Limited, is $0.1608 per ML (NDC 59651040112), effective Jun 24, 2026.
How has the price of CLOBAZAM 2.5 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has declined 46.7%. It has been tracked across 160 weekly CMS publications since Jun 7, 2023.
What are the highest and lowest recorded NADAC prices for CLOBAZAM 2.5 MG/ML SUSPENSION?
Since Jun 7, 2023, the NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has ranged from a low of $0.1530 (May 20, 2026) to a high of $0.3316 (Aug 16, 2023), with a median of $0.1940 per ML.
Are there cheaper alternatives to CLOBAZAM 2.5 MG/ML SUSPENSION?
5 NADAC-published products share the same active ingredient, strength, and dosage form as CLOBAZAM 2.5 MG/ML SUSPENSION, but none are currently priced below it.
Who manufactures CLOBAZAM 2.5 MG/ML SUSPENSION?
CLOBAZAM 2.5 MG/ML SUSPENSION (NDC 59651040112) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification